The Potentially Protective Effect of Donepezil in Alzheimer's Disease

Publisher： Karger

E-ISSN： 1421-9824|38|3-4|170-177

ISSN： 1420-8008

Source： Dementia and Geriatric Cognitive Disorders, Vol.38, Iss.3-4, 2014-04, pp. : 170-177

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Effect of ApoE Genotype on Response to Donepezil in Patients with Alzheimer’s Disease

By  

Dementia and Geriatric Cognitive Disorders, Vol. 25, Iss. 5, 2008-04 ,pp. : 445-450

Karger

Access to resources Recommend Favorite

Cognitive Predictors of Donepezil Therapy Response in Alzheimer Disease

By  

Dementia and Geriatric Cognitive Disorders, Vol. 24, Iss. 1, 2007-05 ,pp. : 28-35

Karger

Access to resources Recommend Favorite

Economic Evaluation of Donepezil Treatment for Alzheimer’s Disease in Japan

By  

Dementia and Geriatric Cognitive Disorders, Vol. 13, Iss. 1, 2001-12 ,pp. : 33-39

Karger

Access to resources Recommend Favorite

Chronic Donepezil Treatment Is Associated with Slowed Cognitive Decline in Alzheimer’s Disease

By  

Dementia and Geriatric Cognitive Disorders, Vol. 12, Iss. 4, 2001-05 ,pp. : 295-300

Karger

Access to resources Recommend Favorite

The Effects of Donepezil in Alzheimer’s Disease – Results from a Multinational Trial1

By  

Dementia and Geriatric Cognitive Disorders, Vol. 10, Iss. 3, 1999-05 ,pp. : 237-244

Karger

Access to resources Recommend Favorite